title: Recent advances in early prostatic cancer.
abstract: Early prostatic carcinoma is a slowly progressing, localized malignant tumor which has been recently discovered with increased frequency due to the use of improved diagnostic methods. The combination of digital rectal examination, serum PSA level and transrectal ultrasound is currently the best available diagnostic tool, although other putative diagnostic markers and techniques are being investigated. Core needle biopsy may follow if there is suspicion of malignancy and in doubtful cases the most useful antibody for the immunohistochemical diagnosis of early, low grade prostatic carcinoma is clone 34 beta E12. Cytogenetic techniques and molecular biological methods are increasingly being used for further investigating localized prostate carcinomas in order to identify early molecular targets and alterations, which may lead to progression. Chromosome abnormalities, cell to cell and cell to matrix interactions, changes in the status of steroid hormone receptors, oncogenes and tumor suppressor genes, as well as other, as yet unclear, events may be of importance in prostate carcinogenesis and the progression of early malignant tumors to aggressive phenotypes. A variety of putative prognostic markers, apart from serum PSA levels, histological grade and tumor volume, such as neuroendocrine differentiation, angiogenesis, cell proliferation labeling index and ploidy analysis may prove useful in evaluating tumor progression in early prostatic carcinomas. The final and most important goal of all investigations related to early prostate cancer is to contribute to the best therapeutic management of the individual patient.
authors.affiliation: Department of Histology and Embryology, School of Medicine, University of Athens, Greece.
authors.forename: V G
authors.initials: VG
authors.lastname: Gorgoulis
authors.forename: D G
authors.initials: DG
authors.lastname: Tiniakos
authors.forename: G
authors.initials: G
authors.lastname: Mariatos
authors.forename: E N
authors.initials: EN
authors.lastname: Manolis
authors.forename: D
authors.initials: D
authors.lastname: Mitropoulos
authors.forename: C
authors.initials: C
authors.lastname: Kittas
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis; D001707:Biopsy, Needle; D002869:Chromosome Aberrations; D018450:Disease Progression; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000235:genetics / Q000628:therapy
chemical_list: D014408:Biomarkers, Tumor